Profilo
Mr. David Caouette is a Vice President-Corporate Communications at Seagen Inc. Mr. Caouette was previously employed as a Head-Media Relations by Biogen, Inc. and a Head-Media Relations by Merck & Co., Inc.
Posizioni attive di David Caouette
| Società | Posizione | Inizio |
|---|---|---|
| SEAGEN INC. | Public Communications Contact | 01/06/2021 |
Precedenti posizioni note di David Caouette
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Public Communications Contact | 01/05/2021 |
| MERCK & CO., INC. | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- David Caouette
